Results

Total Results: 1,112 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase … The diseases covered in the AHRQ review will be defined during the refinement phase.
  2. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - The “track-only” designation means that the intervention is in late-phase trials, but late-phase data … All topics proceed through Phase 1. … Phase 2. … Phase 1 – Internal Expert Comment and Triage (all topics) In Phase 1. … Phase 2 – External Expert Comment Select topics enter Phase 2.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - The “track-only” designation means that the intervention is in late-phase trials, but late-phase data … All topics proceed through Phase 1. … Phase 2. … Phase 1 – Internal Expert Comment and Triage (all topics) In Phase 1. … Phase 2 – External Expert Comment Select topics enter Phase 2.
  4. effectivehealthcare.ahrq.gov/products/quality-rating/research
    November 01, 2011 - A Process for Robust and Transparent Rating of Study Quality: Phase 1 Research Report November 1, 2011 … Purpose To complete the first phase of a project to develop such a methodology, we aimed to examine
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendixes-surveillance-report-1-nonopioid-trtmts-chronic-pain.pdf
    January 01, 2021 - Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised … in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese phase … or chronic low back pain with early pain reduction: an exploratory post-hoc analysis of Japanese phase … Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO- … [TM]s effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
    April 01, 2013 - capecitabine alone HRQL analysis of Cameron 2008, phase III, randomized, open-label, multicenter … Is this study A) a phase III (RCT) trial B) does it address one of the combinations below: AND … Schetelig Level: 2, State: Excluded Refid: 1588, Independent radiologic review of OCEANS, a phase … Vahdat Level: 2, State: Excluded Refid: 1600, Phase II escalation study of sorafenib in patients … Mahner Level: 2, State: Excluded Refid: 1630, A Randomized, Phase II Trial of Standard Triweekly
  7. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - Results The table below lists the eight topics for which (1) preliminary phase III data on drugs, phase … A number of other manufacturers also have all-oral HCV regimens in phase II or phase III development … Sofosbuvir and RBV regimens: In phase III trials, patients infected with HCV genotypes 2 and 3 who … Daclatasvir/sofosbuvir: In a phase II, open-label randomized controlled trial, patients with chronic … In the phase III, randomized controlled VALENCE trial, patients (n=419) with chronic HCV genotype 2
  8. effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
    April 23, 2014 - In addition, the existence of a Part D coverage gap before reaching the catastrophic coverage phase can
  9. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Results The table below lists the three topics for which (1) preliminary phase III or later data were … available for drugs or phase II, III, or later data were available for devices and procedures; (2) … Another drug, roflumilast, failed to meet its primary endpoints in a just-completed phase III trial … The drug is in several phase III clinical trials cosponsored by the Cystic Fibrosis Foundation. … Vertex corrects and provides additional data from recent interim analysis of phase 2 combination
  10. effectivehealthcare.ahrq.gov/products/grant-manuscripts/underperformance-abstract
  11. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the one topic in the system for which (1) preliminary phase III or later … In a randomized, double-blind, placebo-controlled, phase III clinical trial, cosponsored by the Cystic … Vertex Pharmaceuticals initiates phase 3 registration program for VX-770, an oral CFTR potentiator … Final data from phase 2 combination study of VX- 809 and Kalydeco (ivacaftor) showed statistically
  12. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
    January 01, 2012 - III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … The table below lists the eight topics for which (1) preliminary phase III data were available for … The buprenorphine implant is currently in two phase III trials, one of which is funded by the National … Titan Pharmaceuticals presents phase 3 probuphine data at society for Neuroscience annual meeting … Titan Pharmaceuticals announces positive top line results in confirmatory phase 3 trial of probuphine
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase … cognitive rehabilitation therapies, neurorehabilitation, and/or medication used during the non- acute phase
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
    November 01, 2019 - Details for each phase and associated tasks are presented in Table 2. … design phase). … Minimal changes were required during the review phase of the order set prototype. … Group Recommendation Statements by Clinical Phase and Target CDS Channel Task 4. … Categorize Recommendation Statements by Clinical Phase Task 4.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
    January 01, 2013 - active treatments so that they could proceed to phase 3 investigations. … Comparison of error rates in single-arm versus randomized phase II cancer clinical trials. … Incorporating historical control data in planning phase II clinical trials. … for definitive phase III testing. … Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.
  16. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
    October 01, 2014 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the five topics for which (1) preliminary phase III data on drugs or phase … Paul, MN) are in phase III development for DBS for treating MDD. … III clinical trial.7 Three completed phase III trials did not demonstrate superiority of mifepristone … .16 In phase 1, using local anesthesia, a neurosurgeon drills into the patient’s skull and places the
  17. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs, phase … -based phase III trials are ongoing for flutemetamol, and the manufacturer anticipates a premarket … exhibiting raised and normal beta-amyloid levels. 10 Flutemetamol is being investigated in two phasePhase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
    April 10, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  19. effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - Results The table below lists the six topics for which (1) preliminary phase III or later phase data … Phase III trial results are expected in late 2011 and 2012. … The company started phase III trials of a subcutaneous formulation in December 2011. … Pfizer's tofacitinib meets endpoints in final phase III trials. … Trial watch: BLYS-targeted antibody shows promise in Phase III SLE trial.
  20. effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria-quiz.ppt
    September 02, 2013 - Study Eligibility Criteria Interactive Quiz Study Eligibility Criteria Interactive Quiz Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide www.ahrq.gov Study Eligibility Criteria Interactive Quiz This interactive quiz augments the module on st…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: